SmartTRAK will be at this year's #AVA2017 Association for Vascular Access 2017 Annual Scientific Meeting in Phoenix, Arizona. This year's conference promises to be invaluable for industry learnings and networking. Susan Paquette, VP & General Manager SmartTRAK Wound, will also be in attendance, covering the latest research and technologies and participating in this year's informative agenda.
1 min read
SmartTRAK Attending #AVA2017 Association for Vascular Access
Topics:
Wound Care
SmartTRAK News
Continue Reading
1 min read
Bioventus CEO cites SmartTRAK HA Market Stats in Durolane Approval
Durham-based Bioventus has received approval from the U.S. Food and Drug Administration for its treatment, Durolane.
The single-injection product treats knee osteoarthritis pain. The company plans to launch Durolane in the U.S. early next year.
Citing BioMedGPS SmartTRAK, Bioventus CEO Tony Bihl said in an email that “the 2016 entire HA market in the US (1-shot, 2-shot, 3-shot and 5-shot) was about $979 million.”
Topics:
Orthopedics
Continue Reading
1 min read
Key Studies, Trends and Technologies in Neuromodulation
International Neuromodulation Society (INS) President Tim Deer, MD discusses important research results as well as key trends and technologies in neuromodulation.
Timothy Deer, MD, FIPP, President of the International Neuromodulation Society (INS), at the INS 13th Annual Congress May 26-June 3 highlighted key studies, trends and technologies in neuromodulation in an interview with SmartTRAK in Edinburgh, Scotland...
Topics:
Neuro Therapies
Continue Reading
2 min read
India's Cap on Knee implant Pricing May Slow Revenue Growth
Max Retail Pricing for Knees in India Dropping up to 78%
The Indian Government enacted price controls for knee implants capping the price significantly below current market rates. According to a report in IndiaToday , the move is the latest step in the government’s move to bring down the cost of medical devices and pharmaceuticals. The price controls for knee replacement implants caps the price of CoCr knees at ~$852 (54,720 rupees). Ananth Kumar, Minister of Chemicals and Fertilisers, stated current implants are priced at up to ~$3,895 (250K rupees) at Indian hospitals...
Topics:
Orthopedics
Continue Reading
2 min read
OrthoBio Market: SmartTRAK Predicts strong Growth Ahead
Topics:
Orthopedics
Continue Reading
1 min read
Tyler Trapani on Why SmartTRAK is an Essential Business Tool
SmartTRAK Customer Testimonial
SmartTRAK customer Tyler Trapani, Product Manager, tells why SmartTRAK is an essential tool that keeps him up-to-date on market trends and competitors.
Tyler Trapani Video Testimonial
Topics:
SmartTRAK News
Continue Reading
1 min read
Advanced Wound Care Team Welcomes new Biosurgery Analyst
Doug Devens has joined SmartTRAK to cover new Hemostats & Sealants area including Surgical Matrices
SmartTRAK is happy to introduce you to the newest member of the SmartTRAK team, Doug Devens, PhD. Doug will be heading up our Biosurgery efforts, including our newest segment in Advanced Wound Care, Hemostats and Sealants; and Surgical Matrices – both Hernia and Breast. The new Hemostats & Sealants area covers over 27 companies and 55 products on a global basis, with several currently in development.
Topics:
Wound Care
Continue Reading
1 min read
See SmartTRAK 2.0 New Features: View Recorded Webinar
-1.png?t=1500739086786&width=600&height=200&name=Copy%20of%20Email%20Banner%20Recorded%20Webinar%20New%20Features%20(1)-1.png)
We have just launched SmartTRAK 2.0, the premier Business Intelligence Data Platform in the Orthopedics, Wound Care and Neuro Therapies spaces.
Topics:
SmartTRAK News
Continue Reading
1 min read
Innovation and Clinical Outcomes Shaping the Future of Hernia Repair
Continued Shift from Biologic to Synthetic Mesh
Innovation and clinical outcomes are shaping the future of the US ventral hernia market. Over the next several years, the market will see a continued shift from biologic mesh to synthetic mesh, growth in robotic hernia repairs, and an increased focus on clinical efficacy and economic outcomes data that will drive product adoption and impact market shares, particularly in the biosynthetic segment.
Topics:
Wound Care
Continue Reading
1 min read
Tissue Regenix Cites BioMedGPS SmartTRAK as Source
Tissue Regenix cited BioMedGPS SmartTRAK as a source when compiling their Corporate Overview for presentation at the Jeffries Healthcare Conference.
Topics:
SmartTRAK News
Continue Reading
Robust growth is predicted for the US OrthoBio market, driving revenues to over $4B by 2021E according to SmartTRAK projections.